Exploring the Digital Future of Healthcare: Digital Health Investors Panel at RESI Europe

21 Mar

By Karen Deyo, Investor Research Analyst, LSN

Despite the relatively short span of time digital health, as a sector, has been in existence, there has been an explosion in technology and applications in recent years. The increase in digital applications and services, for providers, payers and consumers, is so pronounced, that governments are scrambling to keep up and provide some sort of regulatory framework that can apply to these cutting-edge technologies. From patient disease management to AI-powered diagnostics to EHR management to care coordination, the diversity within digital health can make it difficult to speak to the sector as a whole.

Addressing some of these questions at RESI Europe, the speakers on the Digital Health Investors panel will share their expertise in this area. The panel will take place from 9:00-9:50 AM, and we recommend that anyone interested in an investor’s perspective on the field of digital health attend!

Moderator: Jonas Jendi (Investment Manager, Industrifonden)

Jonas Jendi is an investment manager at Nordic VC Industrifonden (Stockholm), focused on the life science sector. Industrifonden is one of the largest VC funds in the Nordics, focusing on both tech and life science. The €500m evergreen fund invests in early-stage ventures. The Industrifonden life science team currently has a portfolio of 14 companies, from medtech to biotech, both private and publicly traded. Jonas joined Industrifonden in May 2017, bringing onboard recent experience as an independent board member, angel investor and equity analyst. Between 2001 and 2010, Jonas was CEO at Cogmed, a start-up in the field of evidence-based cognitive training (clinically validated software), based in Stockholm and later in the US. Jonas took the company from the research phase at Karolinska Institute in 2001 to acquisition by Pearson in 2010, then managing the Cogmed integration into Pearson. His background also includes strategy work with The Boston Consulting Group.

Lara Koole (Principal, Philips Health Technology Ventures)

Lara leads the European venture capital activities for Philips, includes running the business-independent Philips health technology venture fund focused on investments in early-stage digital health companies to drive strategic value-add relationships with Philips. Looking for driven entrepreneurs that are passionate and capable to address (part of) the quadruple aim in healthcare, improving outcomes and lowering costs while increasing patient and staff satisfaction. Passionate about technology, strategic investing and working together with great teams to scale their companies bringing strategic and industry expertise of Philips to the table.

Tony Chang (Associate, M Ventures)

Tony Chang, PhD, MBA, is an Investment Associate with the New Businesses team at M Ventures. In this role, Tony is focusing on the early stage venture deals in health-tech and digital health, with a particular attention on digital therapeutics deals. Tony has developed substantial experience in assessing digital health deals for both in-clinic and out-of-clinic applications. Prior to M Ventures, Tony was a technology commercialization officer at the University of Western Cape in South Africa where he was responsible for the development of several industry research collaboration and licensing deals. Previously, Tony was a consultant at the strategy practice of EY in Johannesburg.

Thomas Walbert (Digital Health Innovation Manager, weXelerate)

Stephen Kearney is a medical doctor, working with Hannover Re, one of the world’s largest reinsurers. Stephen’s medical speciality is surgery, with experience in academic pathology via lecturing and research, having specialised in cancer genomics and medical informatics. Approximately half of Hannover Re’s business is in the life and health (re)insurance space. Within these verticals, Stephen’s responsibilities include identifying and developing both internal and external innovation opportunities, including in the area of genomics. Besides medicine, Stephen also has academic qualifications and experience in computer science, data analytics and pharmaceutical business, and an undergraduate degree in biochemistry and physics from University College Dublin (UCD).

Stephen Kearney (Innovation – Life & Health, Hannover Re)

Thomas Walbert is the Digital Health Innovation Manager at weXelerate, where he is responsible for building the Health-Cluster program for fostering digital health innovation and managing a network of mentors and experts. Previously, Thomas was a Start-up Consultant at INiTS, a high-tech incubator based in Vienna. He is a start-up enthusiast who is experienced in building environments and networks where corporations and high-tech start-ups can launch revolutionary business models, products, and services.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: